Stock exchange listing
Business news
Today the PolyPeptide Group became a public company. Our shares are being traded on SIX, the Swiss Stock Exchange.
What an exhilarating day! Today the PolyPeptide Group became a public company. Our shares began trading on SIX, the Swiss Stock Exchange. Our entire Executive Committee was there to mark the occasion, including our outgoing CEO Jane Salik and our new CEO Raymond De Vre.
See additional information on our new Investors section